These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24684088)

  • 1. Limits to neoliberal reforms in the health sector: the case of pharmaceutical management in New Zealand.
    Dew K; Davis A
    Int J Health Serv; 2014; 44(1):137-53. PubMed ID: 24684088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging the neoliberal trend: the Venezuelan health care reform alternative.
    Muntaner C; Salazar RM; Rueda S; Armada F
    Can J Public Health; 2006; 97(6):I19-24. PubMed ID: 17203729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key informants' perceptions of how pharmac operates in New Zealand.
    Ragupathy R; Tordoff J; Norris P; Reith D
    Int J Technol Assess Health Care; 2012 Oct; 28(4):367-73. PubMed ID: 23062515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing pharmaceutical expenditure while increasing access. The pharmaceutical management agency (PHARMAC) experience.
    Braae R; McNee W; Moore D
    Pharmacoeconomics; 1999 Dec; 16(6):649-60. PubMed ID: 10724792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Tough but fair"? The active management of the New Zealand drug benefits scheme by an independent Crown agency.
    Davis P
    Aust Health Rev; 2004 Nov; 28(2):171-81. PubMed ID: 15527397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reforms: a quest for efficiency or an opportunity for vested interests'? A case study of pharmaceutical policy reforms in Tanzania.
    Mori AT; Kaale EA; Risha P
    BMC Public Health; 2013 Jul; 13():651. PubMed ID: 23849334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health reform in Mexico: the promotion of inequality.
    Laurell AC
    Int J Health Serv; 2001; 31(2):291-321. PubMed ID: 11407172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why neoliberal health reforms have failed in Latin America.
    Homedes N; Ugalde A
    Health Policy; 2005 Jan; 71(1):83-96. PubMed ID: 15563995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Governing Health Care through Free Choice: Neoliberal Reforms in Denmark and the United States.
    Larsen LT; Stone D
    J Health Polit Policy Law; 2015 Oct; 40(5):941-70. PubMed ID: 26195602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ahead of its time? Reflecting on New Zealand's Pharmac following its 20th anniversary.
    Gauld R
    Pharmacoeconomics; 2014 Oct; 32(10):937-42. PubMed ID: 24906479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing process and politics of health policy in Korea.
    Kwon S; Reich MR
    J Health Polit Policy Law; 2005 Dec; 30(6):1003-26. PubMed ID: 16481306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative to the neoliberal model in health: the case of Venezuela.
    Feo O; Siqueira CE
    Int J Health Serv; 2004; 34(2):365-75. PubMed ID: 15242164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory review: How do agencies ensure the quality of decision making?
    Liberti L; McAuslane N; Patel P; Breckenridge A; Eichler HG; Peterson R
    Clin Pharmacol Ther; 2013 Sep; 94(3):305-8. PubMed ID: 23963218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The politics of pharmaceutical reform: the case of the Philippine National Drug Policy.
    Lee MB
    Int J Health Serv; 1994; 24(3):477-94. PubMed ID: 7928014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global development challenges and health care reform.
    Preker AS
    World Hosp Health Serv; 2001; 37(3):2-8, 40, 42. PubMed ID: 11858008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical regulation in Greece at the crossroad of change: economic, political and constitutional considerations for a new regulatory paradigm.
    Contiades X; Golna C; Souliotis K
    Health Policy; 2007 Jun; 82(1):116-29. PubMed ID: 17049667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decentralization and human resource management in the health sector: a case study (1996-1998) from Nampula province, Mozambique.
    Saide MA; Stewart DE
    Int J Health Plann Manage; 2001; 16(2):155-68. PubMed ID: 11499048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying Programme Budgeting Marginal Analysis in the health sector: 12 years of experience.
    Grocott R
    Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):181-7. PubMed ID: 19402806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoliberal reforms in Swedish primary health care: for whom and for what purpose?
    Dahlgren G
    Int J Health Serv; 2008; 38(4):697-715. PubMed ID: 19069288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoliberal health sector reforms in Latin America: unprepared managers and unhappy workers].
    Ugalde A; Homedes N
    Rev Panam Salud Publica; 2005 Mar; 17(3):202-9. PubMed ID: 15826401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.